These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24513367)

  • 1. Boston keratoprosthesis type 1 device leak.
    Najem K; Sebag M; Harissi-Dagher M
    Can J Ophthalmol; 2014 Feb; 49(1):106-8. PubMed ID: 24513367
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic hypotony associated with the Boston type 1 keratoprosthesis.
    Dokey A; Ramulu PY; Utine CA; Tzu JH; Eberhart CG; Shan S; Gelhbach PL; Akpek EK
    Am J Ophthalmol; 2012 Aug; 154(2):266-271.e1. PubMed ID: 22633347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Boston type 1 keratoprosthesis combined with silicone oil for treatment of hypotony in prephthisical eyes.
    Chan CC; Holland EJ; Sawyer WI; Neff KD; Petersen MR; Riemann CD
    Cornea; 2011 Oct; 30(10):1105-9. PubMed ID: 21642848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Boston Keratoprosthesis type 1 as primary penetrating corneal procedure.
    Fadous R; Levallois-Gignac S; Vaillancourt L; Robert MC; Harissi-Dagher M
    Br J Ophthalmol; 2015 Dec; 99(12):1664-8. PubMed ID: 26034079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complications associated with Boston keratoprosthesis type 1 and glaucoma drainage devices.
    Robert MC; Pomerleau V; Harissi-Dagher M
    Br J Ophthalmol; 2013 May; 97(5):573-7. PubMed ID: 23435225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glaucoma associated with Boston type I keratoprosthesis.
    Kamyar R; Weizer JS; de Paula FH; Stein JD; Moroi SE; John D; Musch DC; Mian SI
    Cornea; 2012 Feb; 31(2):134-9. PubMed ID: 22134402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of bilateral sequential implantation of the Boston keratoprosthesis type 1.
    Vaillancourt L; Papanagnu E; Elfekhfakh M; Fadous R; Harissi-Dagher M
    Can J Ophthalmol; 2017 Feb; 52(1):80-84. PubMed ID: 28237154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glaucoma Risk Factors and Outcomes Following Boston Keratoprosthesis Type 1 Surgery.
    Geoffrion D; Harissi-Dagher M
    Am J Ophthalmol; 2021 Jun; 226():56-67. PubMed ID: 33493469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complications associated with clear corneal cataract wounds during vitrectomy.
    Wong RW; Kokame GT; Mahmoud TH; Mieler WF; Tornambe PE; McDonald HR
    Retina; 2010 Jun; 30(6):850-5. PubMed ID: 20090563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual Outcomes and Complications of Type I Boston Keratoprosthesis in Children: A Retrospective Multicenter Study and Literature Review.
    Fung SSM; Jabbour S; Harissi-Dagher M; Tan RRG; Hamel P; Baig K; Ali A
    Ophthalmology; 2018 Feb; 125(2):153-160. PubMed ID: 28807636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, Risk Factors, and Surgical Management of Boston Type 1 Keratoprothesis Corneal Melts, Leaks, and Extrusions.
    Chan CC; LoVerde L; Qiang J; Nordlund ML; Holland EJ
    Cornea; 2016 Aug; 35(8):1049-56. PubMed ID: 27391092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of vitreoretinal complications in eyes with permanent keratoprosthesis.
    Ray S; Khan BF; Dohlman CH; D'Amico DJ
    Arch Ophthalmol; 2002 May; 120(5):559-66. PubMed ID: 12003604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitreoretinal Complications in Boston Keratoprosthesis Type 1.
    Khair D; Salimi A; Harissi-Dagher M
    Am J Ophthalmol; 2021 Nov; 231():101-108. PubMed ID: 34107311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Boston Keratoprosthesis in severe ocular trauma.
    Harissi-Dagher M; Dohlman CH
    Can J Ophthalmol; 2008 Apr; 43(2):165-9. PubMed ID: 18347618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma-irradiated corneas as carriers for the Boston type 1 keratoprosthesis: advantages and outcomes in a surgical mission setting.
    Fadlallah A; Atallah M; Cherfan G; Awwad ST; Syed ZA; Melki SA
    Cornea; 2014 Mar; 33(3):235-9. PubMed ID: 24457451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis.
    Greiner MA; Li JY; Mannis MJ
    Ophthalmology; 2011 Aug; 118(8):1543-50. PubMed ID: 21397948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Boston keratoprosthesis in Stevens-Johnson syndrome.
    Sayegh RR; Ang LP; Foster CS; Dohlman CH
    Am J Ophthalmol; 2008 Mar; 145(3):438-44. PubMed ID: 18207122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term visual outcomes of the Boston type I keratoprosthesis in Canada.
    Szigiato AA; Bostan C; Nayman T; Harissi-Dagher M
    Br J Ophthalmol; 2020 Nov; 104(11):1601-1607. PubMed ID: 32066560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Boston keratoprosthesis type 1 surgery: use of frozen versus fresh corneal donor carriers.
    Robert MC; Biernacki K; Harissi-Dagher M
    Cornea; 2012 Apr; 31(4):339-45. PubMed ID: 22269678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of bleb excision with free autologous conjunctival patch grafting for bleb leak and hypotony after glaucoma filtering surgery.
    Panday M; Shantha B; George R; Boda S; Vijaya L
    J Glaucoma; 2011 Aug; 20(6):392-7. PubMed ID: 20616750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.